Longevity & Aging · Metabolic & Cardiometabolic
hyperinsulinemia causes insulin resistance
In plain terms: Does high insulin itself cause the body to become insulin resistant rather than the other way around?
Part of: • Insulin & Metabolic Aging
Unsettled. Human studies point to high blood sugar and obesity, rather than high insulin itself, as drivers of insulin resistance, but mouse genetics show that lowering insulin can protect against it, so a role for insulin is not ruled out.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Population patterns (Observational)
How the studies fall
What the evidence shows
Unsettled, and the direction may be the reverse. Sustained physiological hyperglycaemia induced hepatic insulin resistance in healthy adults, and Mendelian randomisation shows obesity causally worsening insulin sensitivity, both pointing upstream of insulin. The supporting evidence is a mouse model where genetically lowering insulin gene dosage prevented diet-induced resistance.
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Tripathy D, Merovci A, Basu R, Abdul-Ghani M, DeFronzo RA 2019 · J Clin Endocrinol Metab | mechanism | contradicts | moderate | Sustained physiologic hyperglycemia induced hepatic insulin resistance in healthy adults, supporting glucose- rather than insulin-driven causation. |
| Gastaldelli A 2017 · Clin Sci (Lond) | observational | contradicts | moderate | Review argues insulin resistance precedes and causes metabolic (NAFLD-linked) hyperinsulinemia, the conventional direction opposite to the claim. |
| Mehran AE, Templeman NM, Brigidi GS, Lim GE, Chu KY, Hu X, Botezelli JD, Asadi A, Hoffman BG, Kieffer TJ, Bamji SX, Clee SM, Johnson JD 2012 · Cell Metabolism | animal | supports | high | Genetically lowering Ins1 dosage to prevent chronic hyperinsulinemia protected mice from diet-induced obesity, adipose inflammation and hepatic steatosis, giving causal genetic evidence that hyperinsulinemia drives the downstream metabolic phenotype rather than merely compensating. |
| Wang T, Ma X, Tang T, Jin L, Peng D, Zhang R, Chen M, Yan J, Wang S, Yan D, He Z, Jiang F, Cheng X, Bao Y, Liu Z, Hu C, Jia W 2016 · Int J Obesity | observational | contradicts | moderate | Mendelian randomization found genetically-instrumented obesity causally worsened insulin sensitivity and secretion, supporting an adiposity-first pathway to insulin resistance/hyperinsulinemia rather than hyperinsulinemia as the root cause. |
| Gusev E, Sarapultsev A, Zhuravleva Y 2026 · Int J Mol Sci | observational | contradicts | low | States IR 'emerges from chronic, metabolically induced inflammation (meta-inflammation) and convergent cellular stress programs' under nutrient excess; frames IR as arising from inflammatory/stress pathways rather than from hyperi |
| Shannon C, Merovci A, Xiong J, Tripathy D, Lorenzo F, McClain D, Abdul-Ghani M, Norton L, DeFronzo RA 2018 · Diabetes | mechanism | mixed | moderate | Human study found chronic hyperglycemia (not hyperinsulinemia) induced insulin resistance, pointing to glucotoxicity rather than insulin itself as causal. |
| Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM 2004 · Diabetes | animal | mixed | moderate | Chronic supraphysiological elevation of a secreted factor (resistin) induced whole-body insulin resistance with secondary hyperinsulinemia in rats, illustrating that hyperinsulinemia is often the downstream consequence of an upstream resistance-inducing signal rather than the initiating cause. |
| Li L, Chen Y, Wang S, Du W, Lao T, Chen F, Yao G, Chen W, Li X, Liu C, Xue X 2025 · Front Endocrinol (Lausanne) | observational | tested-null | low | Narrative review, not evidence: 'We review the epidemiological links, shared risk factors, and mutual influences of clinical management strategies in the comorbidity of diabetes and PC'. Says 'In diabetes, dysregulated autophagy contributes to β-cell failure and insulin resistance' — no test of hyperinsulinemia as a cause. Review — zero weight. |
| DeFronzo RA, Tripathy D 2009 · Diabetes Care | observational | mixed | moderate | Landmark clamp-based synthesis argues skeletal-muscle insulin resistance is the primary, earliest defect in type 2 diabetes with hyperinsulinemia arising as a compensatory beta-cell response, the reverse of Fung's proposed causal direction. |
| Ahmed I, Chakraborty R, Faizy AF, Moin S 2024 · J Diabetes Metab Disord | mechanism | contradicts | low | Review states oxidative stress induces aberrant DNA methylation in beta cells, perpetuating 'beta cell dysfunction' central to T2DM; frames insulin secretion/action impairment as arising from oxidative-epigenetic mechanisms, not f |
| Sundell J, Laine H, Luotolahti M, Nuutila P, Kalliokoski K, Raitakari O, Knuuti J 2003 · Diabetes | mechanism | mixed | moderate | Supraphysiological hyperinsulinemic-euglycemic clamps produced tissue-selective vascular insulin resistance in humans, demonstrating that acutely raising insulin can itself blunt insulin responsiveness in a target tissue, a mechanistic proof-of-principle for insulin-induced resistance. |
| da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE 2020 · Can J Cardiol | mechanism | contradicts | moderate | OFF-SCOPE (narrative 'brief review'): the review asks whether hyperinsulinemia and insulin resistance cause HYPERTENSION and concludes they are not major drivers of BP ('chronic insulin administration does not significantly increase BP in lean or obese insulin resistant rabbits, dogs, horses, or humans'). It does not test or review whether hyperinsulinemia causes insulin resistance; the prior extract's 'or cleanly cause insulin resistance' is not in the paper. |
| Ye C, Dou C, Liu D, Kong L, Chen M, Xu M, Xu Y, Li M, Zhao Z, Zheng J, Lu J, Chen Y, Ning G, Wang W, Bi Y, Wang T 2025 · Nat Commun | observational | tested-null | low | Large multivariate GWAS/MR of insulin resistance identified druggable loci and treated adiposity- and tissue-level resistance as upstream drivers, with fasting insulin modeled as a correlated readout rather than the primary causal origin of insulin resistance. |
| Tarantino G, Citro V, Imbimbo C, Crocetto F 2026 · Int J Mol Sci | mechanism | supports | low | Narrative review, no new data: 'The objective of this narrative review was to provide an overview of the literature concerning the mechanistic pathways linking known risk factors to BC pathogenesis'. On the claim it asserts hyperinsulinemia drives IR: risk factors share 'their role in driving IR due to chronic hyperinsulinemia'; 'High dietary glycemic load and excessive sucrose intake drive chronic hyperinsulinemia, ultimately attenuating insulin signaling and inducing systemic IR'. It also describes 'a vicious cycle where IR leads to compensatory hyperinsulinemia', which is the reverse arm, not a denial. Zero weight as review. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.